Sanofi to work with US institute to try develop vaccine against Zika
PARIS — French pharmaceuticals group Sanofi said on Wednesday it would work with the US Army’s Walter Reed Institute to develop a potential vaccine against the mosquito-borne Zika virus, linked to brain damage in newborns.Sanofi said the Walter Reed Institute would "transfer its Zika … vaccine technology to Sanofi Pasteur", the French group’s vaccines unit, "opening the door for a broader collaboration with the US government." The announcement comes hot on the heels of new research showing two prototype Zika vaccines, one of which was developed by the Walter Reed Institute, providing "complete protection against the Zika virus" in mice.The findings, reported in Nature magazine last month, have boosted hopes that a jab can be developed to shield humans against the virus.In Brazil, about 1.5-million people have been infected with Zika in an outbreak starting last year, and more than 1,600 babies have been born with abnormally small heads and brains.Sanofi Pasteur, which last year brou...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.